Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1654)
Cigna Group (CI)
Cordani David — Director
Shares
38,487
Price
$294.98
Total Value
$11.35M
Shares Held After
88,545
% of Holdings
30.3%
Cigna Group (CI)
Cordani David — Director
Shares
2,142
Price
$293.92
Total Value
$629.57K
Shares Held After
127,032
% of Holdings
1.7%
Cigna Group (CI)
Cordani David — Director
Shares
7,861
Price
$292.88
Total Value
$2.30M
Shares Held After
129,174
% of Holdings
5.7%
Cigna Group (CI)
Cordani David — Director
Shares
12,315
Price
$291.95
Total Value
$3.60M
Shares Held After
137,035
% of Holdings
8.2%
Cigna Group (CI)
Cordani David — Director
Shares
13,732
Price
$291.01
Total Value
$4.00M
Shares Held After
149,350
% of Holdings
8.4%
Cigna Group (CI)
Cordani David — Director
Shares
41,099
Price
$290.00
Total Value
$11.92M
Shares Held After
163,082
% of Holdings
20.1%
Cigna Group (CI)
Cordani David — Director
Shares
13,839
Price
$288.85
Total Value
$4.00M
Shares Held After
204,181
% of Holdings
6.3%
Cigna Group (CI)
Cordani David — Director
Shares
14,292
Price
$287.96
Total Value
$4.12M
Shares Held After
218,020
% of Holdings
6.2%
Cigna Group (CI)
Cordani David — Director
Shares
3,903
Price
$286.83
Total Value
$1.12M
Shares Held After
232,312
% of Holdings
1.7%
NEUROCRINE BIOSCIENCES INC (NBIX)
Norwalk Leslie V — Director
Shares
3,810
Price
$155.01
Total Value
$590.60K
Shares Held After
2,429
% of Holdings
61.1%
LifeStance Health Group, Inc. (LFST)
TPG GP A, LLC — 10% Owner
Shares
28,281,943
Price
$8.02
Total Value
$226.82M
Shares Held After
111,744,614
% of Holdings
20.2%
Lantern Pharma Inc. (LTRN)
KEYSER D JEFFREY — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
94,303
% of Holdings
51.5%
Lantern Pharma Inc. (LTRN)
Schalop Lee Troy — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
48,544
% of Holdings
100.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
6,988
Price
$450.00
Total Value
$3.14M
Shares Held After
26,088
% of Holdings
21.1%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
12,500
Price
$8.01
Total Value
$100.12K
Shares Held After
513,884
% of Holdings
2.4%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
800
Price
$13.83
Total Value
$11.06K
Shares Held After
830,584
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$29.36
Total Value
$186.35K
Shares Held After
69,792
% of Holdings
8.3%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
16,940
Price
$3.29
Total Value
$55.73K
Shares Held After
808,008
% of Holdings
2.1%
ICU MEDICAL INC/DE (ICUI)
Greenberg David C. — Director
Shares
2,424
Price
$122.91
Total Value
$297.93K
Shares Held After
7,960
% of Holdings
23.3%
MANNKIND CORP (MNKD)
Thomson David — EVP Genl Counsel & Secretary
Shares
3,033
Price
$3.29
Total Value
$9.98K
Shares Held After
826,299
% of Holdings
0.4%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
15,647
Price
$22.64
Total Value
$354.25K
Shares Held After
434,357
% of Holdings
3.5%
UFP TECHNOLOGIES INC (UFPT)
CROTEAU DANIEL C — Director
Shares
2,864
Price
$221.71
Total Value
$634.98K
Shares Held After
855
% of Holdings
77.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,800
Price
$73.12
Total Value
$204.74K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,900
Price
$72.15
Total Value
$425.67K
Shares Held After
770,580
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,802
Price
$71.37
Total Value
$699.57K
Shares Held After
776,480
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,398
Price
$70.29
Total Value
$98.26K
Shares Held After
786,282
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
100
Price
$67.85
Total Value
$6.78K
Shares Held After
787,680
% of Holdings
0.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
73,296
Price
$6.20
Total Value
$454.44K
Shares Held After
103,417
% of Holdings
41.5%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
16,961
Price
$4.29
Total Value
$72.82K
Shares Held After
176,293
% of Holdings
8.8%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
5,000
Price
$4.67
Total Value
$23.34K
Shares Held After
256,388
% of Holdings
1.9%
SOPHiA GENETICS SA (SOPH)
HIBBS KATHY L — Director
Shares
7,508
Price
$4.67
Total Value
$35.04K
Shares Held After
89,768
% of Holdings
7.7%
DAVITA INC. (DVA)
Maughan David Paul — Chief Operating Officer, DKC
Shares
13,456
Price
$199.25
Total Value
$2.68M
Shares Held After
94,105
% of Holdings
12.5%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
50,000
Price
$100.32
Total Value
$5.02M
Shares Held After
2,096,504
% of Holdings
2.3%
ANI PHARMACEUTICALS INC (ANIP)
Gutwerg Ori — SVP, GENERICS
Shares
2,772
Price
$79.50
Total Value
$220.37K
Shares Held After
78,696
% of Holdings
3.4%
Senseonics Holdings, Inc. (SENS)
ROEDER DOUGLAS A — Director
Shares
22,686
Price
$5.56
Total Value
$126.13K
Shares Held After
144,635
% of Holdings
15.7%
InspireMD, Inc. (NSPR)
Slosman Marvin — Director
Shares
21,000
Price
$1.20
Total Value
$25.20K
Shares Held After
3,556,658
% of Holdings
0.6%
ANI PHARMACEUTICALS INC (ANIP)
Rowland Thomas Andrew — SVP, HEAD - ESTABLISHED BRANDS
Shares
459
Price
$79.21
Total Value
$36.36K
Shares Held After
38,271
% of Holdings
1.2%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,322
Price
$26.71
Total Value
$88.73K
Shares Held After
466,375
% of Holdings
0.7%
GE HealthCare Technologies Inc. (GEHC)
Hochman Rodney F — Director
Shares
1,618
Price
$62.03
Total Value
$100.36K
Shares Held After
1,618
% of Holdings
100.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,104
Price
$84.59
Total Value
$93.39K
Shares Held After
2,180,000
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
3,307
Price
$83.70
Total Value
$276.80K
Shares Held After
2,181,104
% of Holdings
0.2%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
4,281
Price
$37.09
Total Value
$158.77K
Shares Held After
216,744
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
14,219
Price
$36.64
Total Value
$520.98K
Shares Held After
221,025
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
258
Price
$581.93
Total Value
$150.14K
Shares Held After
5,028
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
56
Price
$583.44
Total Value
$32.67K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$582.80
Total Value
$853.22K
Shares Held After
40,569
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
982
Price
$581.62
Total Value
$571.15K
Shares Held After
42,033
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,706
Price
$580.62
Total Value
$990.53K
Shares Held After
43,015
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$579.67
Total Value
$285.20K
Shares Held After
44,721
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
778
Price
$578.46
Total Value
$450.04K
Shares Held After
45,213
% of Holdings
1.7%
Showing 51–100 of 1654 transactions (page 2 of 34)